3002.12.00.90/Botulinum Toxin Type A Immune Globulin/Japan

Botulinum Toxin Type A Immune Globulin from Japan

Antitoxin derived from human plasma fractions containing antibodies against botulinum toxin, used to treat infant botulism. Classified in HTS 3002.12.0090 as an immunological blood fraction for therapeutic neutralization of toxins. It involves biotech purification of specific antisera.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Include potency assay results (IU/mg) and neutralization efficacy data for CBP clearance

• Ship frozen (-20°C) with chain-of-custody logs to prevent denaturation

• Differentiate from cosmetic botox; declare therapeutic end-use to stay in 3002.12

Botulinum Toxin Type A Immune Globulin from Japan — Import Duty Rate | HTS 3002.12.00.90